Landscape of the immune microenvironment in malignant pleural effusion from EGFR-TKI-resistant NSCLC.
Abstract
e20532 Background: Malignant pleural effusion (MPE) is a poor prognostic factor in non-small cell lung cancer (NSCLC), which often develops resistance to epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs). Depicting the TKI-resistant MPE landscape is key for clarifying resistance mechanisms and finding therapeutic strategies. Methods: We used single-cell RNA sequencing and GO/KEGG/Reactome enrichment analysis to examine the immune microenvironment of fresh MPE samples (n=7), and compared the 3 rd -genration TKI-resistant subgroup (3 rd -GR, n=4) with the 1 st -genration TKI-resistant subgroup (1 st -GR, n=2). Results: 63,843 cells were isolated, with minimal epithelial cells (3.45%) and most being immune cells. T lymphocytes made up the largest proportion (49.72%), followed by macrophages (13.87%, mainly M1 phenotype), monocytes (8.27%), dendritic cells (7.23%), B cells (7.20%), neutrophils (3.01%), natural killer T (NKT) cells (3.00%), natural killer (NK) cells (2.30%), fibroblasts (0.88%), plasma cells (0.59%), mast cells (0.31%) and endothelial cells (0.16%). CD4+ T cells were dominated by Th1-type central memory T (TCM) cells, though few in low/recent activation states. Regulatory T cells (Tregs) were identified as natural central Tregs rather than peripherally induced Tregs. Cell proportions in 3 rd -GR MPE did not differ significantly from those in 1 st -GR MPE. However, cancer cells in 3 rd -GR MPE showed stronger aerobic metabolism and protein synthesis, with reduced adhesion and antigen presentation abilities, and more strongly inhibited apoptotic pathways. Functional differences in immune cells were also seen in 3 rd -GR MPE, showing a more markedly suppressed immune microenvironment. There was a trend toward higher Treg proportions, with significantly enhanced survival/ immunosuppressive capacity, and higher exhausted cytotoxic T lymphocyte (CTL) proportions, with more complete functional collapse. Despite enhanced protein synthesis and direct cytotoxic potential in mucosal-associated invariant T (MAIT) cells, NKT and NK cells, their aerobic metabolism was significantly reduced, insufficient to sustain their functions. Macrophages had weaker adhesion ability; M1 subtypes showed stronger aerobic metabolism and phagocytic/pro-inflammatory activities, but weaker antigen-presenting capacity, while M2 subtypes shifted from aerobic to lipid metabolism, with enhanced anti-inflammatory activity. These findings matched sequential MPE samples from a single patient after developing resistance to 1 st -G and then 3 rd -G TKIs. Conclusions: This study is the first to depict the immune microenvironment of EGFR-TKI resistant MPE. We found far more severe immune suppression in 3rd-GR MPE. These findings may offer a theoretical basis for creating local immunomodulatory strategies to overcome TKI-resistant MPE.
Article Details
Journal Info
Journal of Clinical Oncology
Lippincott Williams & Wilkins
Authors (7)
Yangchun Gu
Peking University Third Hospital, Beijing, China
Abudureyimujiang Aili
Peking University Third Hospital, Beijing, Beijing, China
Zhentao Liu
Peking University Third Hospital, Beijing, China
Lu Yang
Jinyu Yu
Baoshan Cao
Li Liang